Meredith Cummins
Chief Executive Officer
Meredith has been with NeuroEndocrine Cancer Australia since February 2018, first serving as Project Officer / CRA & Nurse Educator before becoming CEO in September 2022. She has been instrumental in the development of the PLANET Registry and Patient App, the Neuroendocrine Cancer Optimal Care Pathway, fully accredited GP and Nurse Education Modules, the Living with Neuroendocrine Cancer Program and advocating for the approval for Belzutifan for VHL patients. Meredith plays an active role in patient support groups and has coordinated numerous Patient Education Forums across the country.
With over 40 years of oncology experience in metropolitan, rural, international, public,…